Oliver J Ziff, Nicholas J Ashton, Puja R Mehta, Rachel Brown, Dilan Athauda, Judith Heaney, Amanda J Heslegrave, Andrea Lessa Benedet, Kaj Blennow, Anna M Checkley, Catherine F Houlihan, Serge Gauthier, Pedro Rosa-Neto, Nick C Fox, Jonathan M Schott, Henrik Zetterberg, Laura A Benjamin, Ross W Paterson
SARS-CoV-2 infection can damage the nervous system with multiple neurological manifestations described. However, there is limited understanding of the mechanisms underlying COVID-19 neurological injury. This is a cross-sectional exploratory prospective biomarker cohort study of 21 patients with COVID-19 neurological syndromes (Guillain-Barre Syndrome [GBS], encephalitis, encephalopathy, acute disseminated encephalomyelitis [ADEM], intracranial hypertension, and central pain syndrome) and 23 healthy COVID-19 negative controls...
April 2022: Journal of Neurochemistry